Pneumologicum Hamburg
- Address
- Valentinskamp 24, 20354 Hamburg, Germany
Pneumologicum Hamburg - Severe Asthma Research
Pneumologicum Hamburg is a specialized respiratory research center focused on advancing treatment strategies for patients with severe asthma. The center conducts innovative clinical trials investigating novel therapeutic approaches that aim to improve long-term asthma control while potentially reducing the burden of daily maintenance medications.
- Biologic therapy optimization in severe asthma patients
- Asthma maintenance therapy reduction strategies
- Long-term asthma control assessment and biomarker evaluation
The center's research program particularly emphasizes evaluating tezepelumab treatment outcomes in adolescents and adults with severe asthma, focusing on the potential to safely reduce conventional asthma medications while maintaining optimal disease control. This work contributes to developing more personalized and potentially less burdensome treatment regimens for patients with difficult-to-control asthma.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pneumologicum Hamburg
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase IIIb Multicenter, Open-Label Study on Tezepelumab for Reducing Maintenance Therapy in Severe Asthma Patients Aged 12-80 Years | AstraZeneca AB | Phase III | Not Recruiting | Nov 2024 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tezepelumab | 1 | Unknown | 2024-11-20 | 2024-11-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.